Nausea
261
12
13
165
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
56 trials with published results (21%)
Research Maturity
165 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.7%
28 terminated out of 261 trials
85.5%
-1.0% vs benchmark
26%
69 trials in Phase 3/4
34%
56 of 165 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 165 completed trials
Clinical Trials (261)
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
Box Breathing for Anxiety, Pain and Nausea in ERCP Patients
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
Subcutaneous Route and Pharmacology of Metoclopramide
Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting
Effect of Antiemetic Timing on Nausea Severity and Patient Comfort in the Emergency Department
Noninvasive Markers of Functional Nausea in Children
Outpatient Oncology Aromatherapy for Symptom Management
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
Management of Nausea and Vomiting Chemotherapy-induced in Normandy
Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days
Inhaled Isopropyl Alcohol for Treatment of Nausea
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
The 4-7-8 Breathing Technique on Pain and Nausea-Vomiting
A Clinical Study to Assess the Effectiveness of ENO Lime in Participants With Ajeerna Vyadhi (Acidity, Acid Indigestion, Indigestion, and Associated Nausea)
The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash
Cannabis For Cancer-Related Symptoms
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide